Literature DB >> 8916621

Dose-effect relations in time-limited psychotherapy for depression.

M Barkham1, A Rees, W B Stiles, D A Shapiro, G E Hardy, S Reynolds.   

Abstract

Criteria for reliable and clinically significant improvement were applied to standard and individually tailored outcome measures data from 212 depressed clients who had been randomly assigned to receive either 8 or 16 sessions of time-limiting psychotherapy. The data were used to address 2 questions: (a) Is the dose-effect curve for psychological symptoms negatively accelerated? and (b) is there a differential rate of response for acute, chronic, and characterological/interpersonal components of depression? The results supported the differential rate of response of different components of depression and suggested qualifications to the acute, chronic, and characterological/interpersonal components and evidence that both supported and qualified previous suggestions that the dose-effect curve is negatively accelerated.

Entities:  

Mesh:

Year:  1996        PMID: 8916621     DOI: 10.1037//0022-006x.64.5.927

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  19 in total

1.  The trajectory of change for children and youth in residential treatment.

Authors:  J W Noftle; S Cook; A Leschied; J St Pierre; S L Stewart; A M Johnson
Journal:  Child Psychiatry Hum Dev       Date:  2011-02

2.  Longitudinal Analysis when the Experimenter does not Determine when Treatment Ends: What is Dose-Response?

Authors:  Daniel J Feaster; Frederick L Newman; Christopher Rice
Journal:  Clin Psychol Psychother       Date:  2003

3.  Effectiveness of Briefer Coping-Focused Psychotherapy for Common Mental Complaints on Work-Participation and Mental Health: A Pragmatic Randomized Trial with 2-Year Follow-Up.

Authors:  M E A Wormgoor; A Indahl; E Andersen; J Egeland
Journal:  J Occup Rehabil       Date:  2020-03

4.  Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.

Authors:  Denise A Hien; Aimee N C Campbell; Lesia M Ruglass; Lissette Saavedra; Abigail G Mathews; Grace Kiriakos; Antonio Morgan-Lopez
Journal:  J Subst Abuse Treat       Date:  2015-04-07

5.  Cognitive Behavioral Therapy for Depressed Adults with Mild Intellectual Disability: A Pilot Study.

Authors:  Sigan L Hartley; Anna J Esbensen; Rebecca Shalev; Lori B Vincent; Iulia Mihaila; Paige Bussanich
Journal:  J Ment Health Res Intellect Disabil       Date:  2015-04-06

Review 6.  A review of empirically supported psychological therapies for mood disorders in adults.

Authors:  Steven D Hollon; Kathryn Ponniah
Journal:  Depress Anxiety       Date:  2010-10       Impact factor: 6.505

7.  College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity.

Authors:  Maren Nyer; David Mischoulon; Jonathan E Alpert; Daphne J Holt; Charlotte D Brill; Albert Yeung; Paola Pedrelli; Lee Baer; Christina Dording; Ilana Huz; Lauren Fisher; Maurizio Fava; Amy Farabaugh
Journal:  Ann Clin Psychiatry       Date:  2015-05       Impact factor: 1.567

Review 8.  Adolescent substance abuse treatment: evidence-based practice in outpatient services.

Authors:  Yifrah Kaminer
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

9.  The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition.

Authors:  Louis S Matza; Kathleen W Wyrwich; Glenn A Phillips; Lindsey T Murray; Karen G Malley; Dennis A Revicki
Journal:  Qual Life Res       Date:  2012-03-09       Impact factor: 4.147

10.  Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial.

Authors:  Gilles Ambresin; Jean-Nicolas Despland; Martin Preisig; Yves de Roten
Journal:  BMC Psychiatry       Date:  2012-10-30       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.